Abstract
Resveratrol is a plant phenolic phytoalexin that has been reported to have antitumor properties in several types of cancers. In particular, several studies have suggested that resveratrol exerts antiproliferative effects against A549 human non-small cell lung cancer cells; however, its mechanism of action remains incompletely understood. Deregulation of microRNAs (miRNAs), a class of small, noncoding, regulatory RNA molecules involved in gene expression, is strongly correlated with lung cancer. In this study, we demonstrated that resveratrol treatment altered miRNA expression in A549 cells. Using microarray analysis, we identified 71 miRNAs exhibiting greater than 2-fold expression changes in resveratrol-treated cells relative to their expression levels in untreated cells. Furthermore, we identified target genes related to apoptosis, cell cycle regulation, cell proliferation, and differentiation using a miRNA target-prediction program. In conclusion, our data demonstrate that resveratrol induces considerable changes in the miRNA expression profiles of A549 cells, suggesting a novel approach for studying the anticancer mechanisms of resveratrol.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aggarwal, B.B., Bhardwaj, A., Aggarwal, R.S., Seeram, N.P., Shishodia, S., and Takada, Y. (2004). Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 24, 2783–2840.
Ambros, V., and Chen, X. (2007). The regulation of genes and genomes by small RNAs. Development 134, 1635–1641.
Ambros, V., and Lee, R.C. (2004). Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol. Biol. 265, 131–158.
Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297.
Bhat, K.P., and Pezzuto, J.M. (2002). Cancer chemopreventive activity of resveratrol. Ann. N. Y. Acad. Sci. 957, 210–229.
Bhat, K.P.L., Kosmeder, J.W.2nd., and Pezzuto, J.M. (2001). Biological effects of resveratrol. Antioxid. Redox. Signal. 3, 1041–1064.
Calin, G.A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S.E., Iorio, M.V., Visone, R., Sever, N.I., Fabbri, M., et al. (2005). A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353, 1793–1801.
Chen, J.F., Mandel, E.M., Thomson, J.M., Wu, Q., Callis, T.E., Hammond, S.M., Conlon, F.L., and Wang, D.Z. (2006). The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228–233.
Cheng, A.M., Byrom, M.W., Shelton, J., and Ford, L.P. (2005). Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33, 1290–1297.
Cho, W.J., Shin, J.M., Kim, J.S., Lee, M.R., Hong, K.S., Lee, J.H., Koo, K.H., Park, J.W., and Kim, K.S. (2009). miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. Mol. Cells 28, 521–527.
Delmas, D., Jannin, B., and Latruffe, N. (2005). Resveratrol: preventing properties against vascular alterations and ageing. Mol. Nutr. Food. Res. 49, 377–395.
Eder, M., and Scherr, M. (2005). MicroRNA and lung cancer. N. Engl. J. Med. 352, 2446–2448.
Faber, A.C., and Chilles, T.C. (2006). Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: evidence for a novel mechanism involving inhibition of BCL6 signaling. Int. J. Oncol. 29, 1561–1566.
Guo L., and Lu, Z. (2010). The fate of miRNA* strand through Evolutionary anlysis: Implication for degradation as carrier strand or potential regulatory molecules? PLoS One 5, e11387
He, L., Thomson, J.M., Hemann, M.T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S.W., Hannon, G.J., et al. (2005). A microRNA polycistron as a potential human oncogene. Nature 435, 828–833.
John, B., Enright, A.J., Aravin, A., Tuschl, T., Sander, C., and Marks, D.S. (2004). Human MicroRNA targets. PLoS Biol. 2, e363.
Johnson, S.M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K.L., Brown, D., and Slack, F.J. (2005). RAS is regulated by the let-7 microRNA family. Cell 120, 635–647.
Kasdallah-Grissa, A., Mornagui, B., Aouani, E., Hammami, M., El May, M., Gharbi, N., Kamoun, A., and El-Fazaa, S. (2007). Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci. 80, 1033–1039.
Kim, Y.A., Lee, W.H., Choi, T.H., Rhee, S.H., Park, K.Y., and Choi, Y.H. (2003). Involvement of p21WAF1/CIP1, pRB, Bax and NFkappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells. Int. J. Oncol. 23, 1143–1149.
Kundu, J.K., and Surh, Y.J. (2004). Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat. Res. 555, 65–80.
Logarajah, S., Hunter, P., Kraman, M., Steele, D., Lakhani, S., Bobrow, L., Venkitaraman, A., and Wagner, S. (2003). BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation. Oncogene 22, 5572–5578.
Ma, X.D., Yan, F., Ma, A.D., and Wang, H.J. (2006). Resveratrol induces HepG2 cell apoptosis by depolarizing mitochondrial membrane. Nan Fang Yi Ke Da Xue Xue Bao 26, 406–408.
Matsuoka, A., Furuta, A., Ozaki, M., Fukuhara, K., and Miyata, N. (2001). Resveratrol, a naturally occurring polyphenol, induces sister chromatid exchanges in a Chinese hamster lung (CHL) cell line. Mutat. Res. 494, 107–113.
Moammir, H.A., Minakshi, N., Vivian, X.F., David, F.J., and Nihal, A. (2006). Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Mol. Cancer Ther. 5, 1335–1341.
Mollerup, S., Ovrebo, S., and Haugen, A. (2001). Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells. Int. J. Cancer 92, 18–25.
Nana-Sinkam, S.P., and Geraci, M.W. (2006). MicroRNA in lung cancer. J. Thorac. Oncol. 1, 929–931.
O’Toole, A.S., Miller, S., Haines, N., Zink, M.C., and Serra, M.J. (2006). Comprehensive thermodynamic analysis of 3′doublenucleotide overhangs neighboring Watson-Crick terminal pairs. Nucleic Acids Res. 34, 3338–3344.
Park, J.S., Kim, K.M., Kim, M.H., Chang, H.J., Baek, M.K., Kim, S.M., and Jung, Y.D. (2009). Resveratrol inhibits tumor cell adhension to endothetial cells by blocking ICAM-1 expression. Anticancer Res. 29, 355–362.
Pillai, R.S., Bhattacharyya, S.N., and Filipowicz, W. (2007). Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol. 17, 118–126.
Plasterk, R.H. (2006). Micro RNAs in animal development. Cell 124, 877–881.
Rana, T.M. (2007). Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell. Biol. 8, 23–36.
Revel, A., Raanani, H., Younglai, E., Xu, J., Rogers, I., Han, R., Savouret, J.F., and Casper, R.F. (2003). Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J. Appl. Toxicol. 23, 255–261.
Schneider, Y., Vincent, F., Duranton, B., Badolo, L., Gosse, F., Bergmann, C., Seiler, N., and Raul, F. (2000). Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 158, 85–91.
Soleas, G.J., Diamandis, E.P., and Goldberg, D.M. (1997). Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30, 91–113.
Staudt, L.M., Dent, A.L., Shaffer, A.L., and Yu, X. (1999). Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6. Int. Rev. Immunol. 18, 381–403.
Stef, G., Csiszar, A., Lerea, K., Ungvari, Z., and Veress, G. (2006). Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance. J. Cardiovasc. Pharmacol. 48, 1–5.
Stervbo, U., Vang, O., and Bonnesen, C. (2006). Time-and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Cell Prolif. 39, 479–493.
Stewart, J.R., Artime, M.C., and O’Brian, C.A. (2003). Resveratrol: a candidate nutritional substance for prostate cancer prevention. J. Nutr. 133, 2440S–2443S.
Sun, C., Hu, Y., Liu, X., Wu, T., Wang, Y., He, W., and Wei, W. (2006). Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis. Cancer Genet. Cytogenet. 165, 9–19.
Zhang, B., Wang, Q., and Pan, X. (2007). MicroRNAs and their regulatory roles in animals and plants. J. Cell. Physiol. 210, 279–289.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Bae, S., Lee, EM., Cha, H.J. et al. Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells. Mol Cells 32, 243–249 (2011). https://doi.org/10.1007/s10059-011-1037-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-011-1037-z